Additionally, the high expression of caveolin-1 in tumor stroma, a significant component of caveolae, has been associated with improved responses to albumin-conjugated drugs in non-small cell lung cancer (NSCLC) patients [20,56]. The gene discussed is ALB; the disease is non-small cell lung carcinoma.